Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Vertex rev. argent. psiquiatr ; 24(109): 194-205, 2013 May-Jun.
Article Dans Espagnol | LILACS, BINACIS | ID: biblio-1176906

Résumé

In the present article we will show the results of the workshop known as The First Training Psychiatrists Latin-American Meeting (2012). We will explore as well, the impact of the psychiatric practice on young physicians who look to the specialty. In this article we intend to update existing bibliography on the subject, and share the results of two research studies done by this team: a questionnaire conducted to first year medical residents working in Metropolitan Buenos Aires (2008/9) and a workshop carried out with the participants of the Latin- American meeting mentioned above.


Sujets)
Psychiatrie/enseignement et éducation , Enseignement médical/normes , Humains
2.
Vertex rev. argent. psiquiatr ; 19(77): 512-521, ene.- feb. 2008. tab
Article Dans Espagnol | LILACS | ID: lil-539679

Résumé

El objetivo de la presente actualización farmacológica es abordar la problemática de la dependencia alcohólica. Partiendo de las bases biológicas y del impacto del etanol sobre los sistemas neurobiológicos y de neurotransmisión, se hará una revisión de las principales herramientas farmacológicas para el tratamiento de la dependencia alcohólica. El disulfiram, la naltrexona y el acamprosato, todas ellas con aprobación por la FDA (Food and Drug Administration) han mostrado mecanismos de acción, perfiles de eficacia, tolerabilidad y adherencia dispares. También nos referiremos al topiramato, el que está siendo estudiado actualmente con relación a esta indicación.


The aim of the present pharmacological update is to revise the problem of alcohol dependence. Starting from the biological bases and the impact of alcohol on the neurobiological and neurotransmission systems, a revision of the main pharmacological tools for alcohol dependence treatment will be done. Disulfiram, naltrexone, acamprosate, all of them approved by the FDA (Food and Drug Administration), have shown mechanisms of action, efficacy, tolerance and adherence dissimilar. We will also refer to topiramate, which is being studied for this indication.


Sujets)
Humains , Alcoolisme/rééducation et réadaptation , Substances à effet antabuse/usage thérapeutique , Disulfirame/usage thérapeutique , Fructose/analogues et dérivés , Naltrexone/usage thérapeutique , Taurine/analogues et dérivés , Substances à effet antabuse/effets indésirables , Disulfirame/effets indésirables , Fructose/effets indésirables , Fructose/usage thérapeutique , Naltrexone/effets indésirables , Taurine/effets indésirables , Taurine/usage thérapeutique
SÉLECTION CITATIONS
Détails de la recherche